Literature DB >> 1739294

Necrobiotic xanthogranuloma.

D A Mehregan1, R K Winkelmann.   

Abstract

We reviewed 32 cases of necrobiotic xanthogranuloma and 16 cases from the world literature. Necrobiotic xanthogranuloma is a destructive dermal and subcutaneous xanthogranuloma that most frequently involves the face (periorbital region) and trunk. Monoclonal gammopathy is common (IgG-kappa in 23 cases and IgG-lambda in nine cases), and cryoglobulins have also been found. Low complement levels, anemia, and leukopenia are frequently present. Bone marrow examination shows plasma cell proliferation and, rarely, true myeloma. We describe mucosal, muscle, and systemic lesions, including xanthogranulomatous myocardial lesions. The clinical course is chronic and often progressive. Low-dose chlorambucil treatment is safe and effective, but individual patients have responded to treatment with corticosteroids, melphalan, local radiation, and plasma exchange.

Entities:  

Mesh:

Year:  1992        PMID: 1739294

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  18 in total

1.  Necrobiotic xanthogranuloma.

Authors:  Yvonne Efebera
Journal:  Clin Adv Hematol Oncol       Date:  2011-09

2.  [Disseminated asymptomatic nodules and plaques].

Authors:  C Appelhans; J Wundenberg; F Breuckmann; P Altmeyer; A Kreuter
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 3.  Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

Authors:  J A Sivak-Callcott; J Rootman; S L Rasmussen; R A Nugent; V A White; D Paridaens; Z Currie; G Rose; B Clark; A A McNab; F V Buffam; J M Neigel; M Kazim
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

4.  [Long-term course of necrobiotic xanthogranuloma with ocular involvement].

Authors:  S Meyer; M Landthaler; S Hohenleutner
Journal:  Hautarzt       Date:  2006-02       Impact factor: 0.751

Review 5.  Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.

Authors:  Yvonne Efebera; Elizabeth Blanchard; Charles Allam; Andrew Han; Saem Lee; Nikhil Munshi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-04-20

6.  Local corticosteroid treatment of eyelid and orbital xanthogranuloma.

Authors:  Victor M Elner; Roni Mintz; Hakan Demirci; Adam S Hassan
Journal:  Trans Am Ophthalmol Soc       Date:  2005

7.  Periocular xanthogranuloma: A forgotten entity?

Authors:  Charalampos Papagoras; George Kitsos; Paraskevi V Voulgari; Anastasia K Zikou; Maria I Argyropoulou; Aikaterini Zioga; Alexandros A Drosos
Journal:  Clin Ophthalmol       Date:  2010-03-04

8.  Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis.

Authors:  M Jeziorska; A Hassan; M I Mackness; D E Woolley; A B Tullo; G S Lucas; P N Durrington
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

9.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

10.  Periocular xanthogranulomas associated with severe adult-onset asthma.

Authors:  F A Jakobiec; M D Mills; A A Hidayat; R L Dallow; D J Townsend; E A Brinker; N C Charles
Journal:  Trans Am Ophthalmol Soc       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.